One major study published in early 2025, which followed over 351,000 adults, found no statistically significant increase in the long-term risk of thyroid cancer for those taking GLP-1 medications compared to those on other diabetes drugs
This compound is intended for in-vitro biochemical assays to study GLP-1 receptor ligand binding and protein-peptide interactions
The Knowledge Hub Drinking Differently: How GLP-1 Medications Impact Alcohol Consumption Whitepaper | How GLP-1 Medications Impact Alcohol Consumption About Following our previous research into how GLP-1 medications are changing eating behaviour, KAM partnered with Drinkaware to explore another key question for hospitality and drinks brands: how are these medications affecting alcohol consumption
The subsequent sections of this article will provide detailed information on each aspect, helping readers to stay informed and prepared
Some preclinical and early-phase clinical studies suggest these medications may have potential neuroprotective properties , though this research remains investigational
Ultrastructural distribution of glutathione demonstrated by NTN and TuMV infections